The S&P 500 was down 0.3% to 4,144.10.
The Dow 30 declined 0.5% to 32,665.51.
The Nasdaq was flat at 12,665.81.
Crude oil fell 3.2% to $87.77 a barrel.
Gold was up 1.7% to $1,807 an ounce.
The yield on a 10-year bond declined 1.89% to 2.696%.
TTM Technologies Inc. (Nasdaq: TTMI) jumped 19% to $16.07 and a $1.6 billion market cap. The Santa Ana-based maker of radio frequency components and printed circuit boards reported a second-quarter adjusted profit of 54 cents a share when the consensus analyst estimate was 33 cents. It also posted revenue of $625.6 million, which topped the average estimate of $600.4 million.
Romeo Power Inc. (NYSE: RMO) climbed 8.8% to 85 cents and a $129 million market cap. The Cypress-based maker of electric batteries is being bought by Nikola Corp., a Phoenix-based maker of electric vehicles. When the announcement was made on Aug. 1, shares of Romeo jumped 25%. The all-stock transaction for Romeo is linked to the share price of Nikola, which reported second-quarter results today and climbed 4.6% to $7.82 and a $3.3 billion market cap (Nasdaq: NKLA).
–Peter J. Brennan
Major U.S. stock indexes surged in Wednesday midday trading, led by a 2.6% jump in the Nasdaq to 12,667.92, as Wall Street recovered losses from earlier this week and major companies reported solid earnings.
The S&P 500 rose 1.6% to 4,157.98.
The Dow 30 was up 1.4% to 32,841.03.
The yield on a 10-year Treasury bond increased 1.3% to 2.776%.
The price of gold was down 0.8% to $1,775.40.
The price for a barrel of oil fell 3.3% to $91.35.
Irvine-based data analytics software maker Alteryx Inc. (NYSE: AYX) surged 21% to $60.94 for a market cap of $4.2 billion. The increase adds to Tuesday’s gains after the firm reported second-quarter earnings that far surpassed analyst estimates, with revenue surging 50% to $180.6 million. Analysts had expected revenue of $161 million. The company also raised its full-year guidance.
MDxHealth SA (Nasdaq:MDXH) jumped 16% to $7.61 per share for a $118.7 million market cap after the Belgium and Irvine-based diagnostics company announced it would acquire Exact Sciences Corp.’s genomic prostate test, Oncotype DX® GPS, along with most of its team of urology sales and marketing staff. The company also yesterday reported strong preliminary financial results for the half year ended June 30, 2022 and raised its full year 2022 revenue guidance.
The S&P 500 rose 0.1% to 4,122.12 in midday trading.
The yield on a 10-year Treasury bond jumped 3.2% to 2.688%.
Irvine-based data analytics software maker Alteryx Inc. (NYSE: AYX) rose 4% to $50.47 for a market cap of $3.4 billion. The company, whose shares have risen 5% over the past week, is scheduled to release second-quarter earnings later today.
The S&P 500 index rose 0.9% to 4,109.26 in midday trading.
The Dow 30 increased 0.6% to 32,718.06.
Nasdaq jumped 1.2% to 12,310.75.
Crude oil increased 3.5% to $99.81 a barrel.
Gold climbed 0.6% to $1,779.10 an ounce.
The yield on a 10-year bond fell 1.68% to 2.636%.
Resources Connection Inc. (Nasdaq: RGP) rose 13% to $22.89 and a $757 million market cap. The Irvine-based global consulting firm yesterday reported fiscal fourth-quarter revenue increased 26% to $217 million. “We are very excited to have produced the strongest revenue and adjusted EBITDA we’ve seen in over ten years for both the fourth quarter and full fiscal year,” Chief Executive Kate Duchene said in a statement.
Edwards Lifesciences Corp., Orange County’s most valuable publicly traded company (NYSE: EW), fell 6% to $100.85 and a $63.7 billion market cap. The Irvine-based maker of artificial heart valves yesterday reported second-quarter sales that missed analysts’ consensus estimates and it lowered its 2022 forecast.
–Peter J. Brennan